Connecting you to content on EBSCOhost

Works matching IS 26628651 AND DT 2022 AND VI 3 AND IP 1

Results: 4

1

The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development.

Published in:

Molecular Biomedicine, 2022, v. 3, n. 1, p. 1, doi. 10.1186/s43556-022-00106-y

By:

Yan, Weizhu;
Zheng, Yanhui;
Dou, Chao;
Zhang, Guixiang;
Arnaout, Toufic;
Cheng, Wei

Publication type:

Article

2

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy.

Published in:

Molecular Biomedicine, 2022, v. 3, n. 1, p. 1, doi. 10.1186/s43556-022-00110-2

By:

Li, Qingfang;
Li, Zhihui;
Luo, Ting;
Shi, Huashan

Publication type:

Article

3

An overview of PROTACs: a promising drug discovery paradigm.

Published in:

Molecular Biomedicine, 2022, v. 3, n. 1, p. 1, doi. 10.1186/s43556-022-00112-0

By:

Liu, Zi;
Hu, Mingxing;
Yang, Yu;
Du, Chenghao;
Zhou, Haoxuan;
Liu, Chengyali;
Chen, Yuanwei;
Fan, Lei;
Ma, Hongqun;
Gong, Youling;
Xie, Yongmei

Publication type:

Article

4

TGF-beta signal transduction: biology, function and therapy for diseases.

Published in:

Molecular Biomedicine, 2022, v. 3, n. 1, p. 1, doi. 10.1186/s43556-022-00109-9

By:

Tie, Yan;
Tang, Fan;
Peng, Dandan;
Zhang, Ye;
Shi, Huashan

Publication type:

Article